Technical view on 4 breakout stocks:
NMDC
Current Price: ₹71.87 Likely Target: ₹82 Upside Potential: 14.1% Support: ₹70.36; ₹69.72; ₹68.63 Resistance: ₹74.50; ₹78 NMDC stock is likely to trade with a favourable bias as long as the stock holds above ₹68.63; with near support likely around the 50-Day Moving Average (50-DMA) at ₹70.36 and the 20-DMA at ₹69.72. On the upside, the stock is likely to target ₹82 levels in the near-term. Intermediate resistance can be anticipated around ₹74.50 and ₹78 levels.Godrej Agrovet
Current Price: ₹847 Likely Target: ₹1,000 Upside Potential: 18.1% Support: ₹811; ₹796; ₹790 Resistance: ₹895; ₹944 Godrej Agro stock is likely to trade on an upbeat note as long as the stock holds above ₹846. The overall bias is likely to remain positive above ₹790 levels; with interim support visible at ₹811 and ₹796 levels. On the upside, the stock can potentially soar towards ₹1,000-mark; thus implying an upside potential of 18 per cent from present levels. Intermediate resistance for the stock can be anticipated around ₹895 and ₹944 levels.Concord Biotech
Current Price: ₹1,891 Likely Target: ₹2,250 Upside Potential: 19% Support: ₹1,874; ₹1,840; ₹1,825; ₹1,770 Resistance: ₹2,050; ₹2,150 Concord Biotech has given a breakout above the super trend line, and also seen consolidating above its 200-DMA, which stands at ₹1,874. The bias at the counter is likely to remain favourable as long as the stock trades above ₹1,770 levels; with intermediate support expected around ₹1,840 and ₹1,825 levels. On the upside, the stock can potentially rally towards ₹2,250 levels, with interim resistance likely around ₹2,050 and ₹2,150 levels.Amara Raja Energy & Mobility (ARE & M)
Current Price: ₹995 Likely Target: ₹1,130 Upside Potential: 13.6% Support: ₹980; ₹951 Resistance: ₹1,053; ₹1,096 ARE & M stock seems to be recouping from the earlier sharp fall. The bias at the counter is likely to be cautiously optimistic as long as the stock holds above ₹951 levels, with near support seen at ₹980 levels. On the upside, the stock may extend the recovery and aim to test its 200-DMA, which now quotes at ₹1,096 levels, above which a spurt towards ₹1,130 seems likely. Interim resistance for the stock can be anticipated around ₹1,053 levels.One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)